Abveris Announces Antibody Discovery Agreement with Immunitas Using the Berkeley Lights Beacon® October 8, 2020
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide October 5, 2020
Bicycle Therapeutics Announces Gross Proceeds of $50.0 Million from its At-the-Market Offering Program and Enters into Debt Financing from Hercules Capital October 2, 2020
Momenta Pharmaceuticals, founded by Christoph Westphal as CEO, Announces Completion of Proposed Sale to Johnson & Johnson October 1, 2020
